222 related articles for article (PubMed ID: 21546572)
1. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis.
Banh A; Zhang J; Cao H; Bouley DM; Kwok S; Kong C; Giaccia AJ; Koong AC; Le QT
Cancer Res; 2011 Jul; 71(13):4423-31. PubMed ID: 21546572
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.
Kuo P; Bratman SV; Shultz DB; von Eyben R; Chan C; Wang Z; Say C; Gupta A; Loo BW; Giaccia AJ; Koong AC; Diehn M; Le QT
Clin Cancer Res; 2014 Nov; 20(21):5558-69. PubMed ID: 25189484
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1.
Kovács-Sólyom F; Blaskó A; Fajka-Boja R; Katona RL; Végh L; Novák J; Szebeni GJ; Krenács L; Uher F; Tubak V; Kiss R; Monostori E
Immunol Lett; 2010 Jan; 127(2):108-18. PubMed ID: 19874850
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is a local but not systemic immunomodulatory factor in mesenchymal stromal cells.
Fajka-Boja R; Urbán VS; Szebeni GJ; Czibula Á; Blaskó A; Kriston-Pál É; Makra I; Hornung Á; Szabó E; Uher F; Than NG; Monostori É
Cytotherapy; 2016 Mar; 18(3):360-70. PubMed ID: 26857229
[TBL] [Abstract][Full Text] [Related]
5. Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
Cedeno-Laurent F; Barthel SR; Opperman MJ; Lee DM; Clark RA; Dimitroff CJ
J Immunol; 2010 Oct; 185(8):4659-72. PubMed ID: 20844192
[TBL] [Abstract][Full Text] [Related]
6. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.
Perone MJ; Larregina AT; Shufesky WJ; Papworth GD; Sullivan ML; Zahorchak AF; Stolz DB; Baum LG; Watkins SC; Thomson AW; Morelli AE
J Immunol; 2006 Jun; 176(12):7207-20. PubMed ID: 16751364
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.
Corapi E; Carrizo G; Compagno D; Laderach D
Front Immunol; 2018; 9():2190. PubMed ID: 30319642
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
Kuo PL; Hung JY; Huang SK; Chou SH; Cheng DE; Jong YJ; Hung CH; Yang CJ; Tsai YM; Hsu YL; Huang MS
J Immunol; 2011 Feb; 186(3):1521-30. PubMed ID: 21191065
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion.
Stowell SR; Qian Y; Karmakar S; Koyama NS; Dias-Baruffi M; Leffler H; McEver RP; Cummings RD
J Immunol; 2008 Mar; 180(5):3091-102. PubMed ID: 18292532
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor.
Kuo PL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH
J Biol Chem; 2012 Mar; 287(13):9753-9764. PubMed ID: 22291012
[TBL] [Abstract][Full Text] [Related]
11. Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of T cell responses.
Tribulatti MV; Figini MG; Carabelli J; Cattaneo V; Campetella O
J Immunol; 2012 Apr; 188(7):2991-9. PubMed ID: 22357632
[TBL] [Abstract][Full Text] [Related]
12. Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.
Cedeno-Laurent F; Opperman MJ; Barthel SR; Hays D; Schatton T; Zhan Q; He X; Matta KL; Supko JG; Frank MH; Murphy GF; Dimitroff CJ
J Invest Dermatol; 2012 Feb; 132(2):410-20. PubMed ID: 22158550
[TBL] [Abstract][Full Text] [Related]
13. Suppression of autoimmune diabetes by soluble galectin-1.
Perone MJ; Bertera S; Shufesky WJ; Divito SJ; Montecalvo A; Mathers AR; Larregina AT; Pang M; Seth N; Wucherpfennig KW; Trucco M; Baum LG; Morelli AE
J Immunol; 2009 Mar; 182(5):2641-53. PubMed ID: 19234158
[TBL] [Abstract][Full Text] [Related]
14. Regulation of eosinophilia and allergic airway inflammation by the glycan-binding protein galectin-1.
Ge XN; Ha SG; Greenberg YG; Rao A; Bastan I; Blidner AG; Rao SP; Rabinovich GA; Sriramarao P
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):E4837-46. PubMed ID: 27457925
[TBL] [Abstract][Full Text] [Related]
15. Galectin-1 tunes TCR binding and signal transduction to regulate CD8 burst size.
Liu SD; Tomassian T; Bruhn KW; Miller JF; Poirier F; Miceli MC
J Immunol; 2009 May; 182(9):5283-95. PubMed ID: 19380775
[TBL] [Abstract][Full Text] [Related]
16. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
[TBL] [Abstract][Full Text] [Related]
17. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Fukumori T; Takenaka Y; Yoshii T; Kim HR; Hogan V; Inohara H; Kagawa S; Raz A
Cancer Res; 2003 Dec; 63(23):8302-11. PubMed ID: 14678989
[TBL] [Abstract][Full Text] [Related]
18. Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway.
Hsu YL; Wu CY; Hung JY; Lin YS; Huang MS; Kuo PL
Carcinogenesis; 2013 Jun; 34(6):1370-81. PubMed ID: 23389289
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
Hsu YL; Hung JY; Chiang SY; Jian SF; Wu CY; Lin YS; Tsai YM; Chou SH; Tsai MJ; Kuo PL
Oncotarget; 2016 May; 7(19):27584-98. PubMed ID: 27050278
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
Leung Z; Ko FCF; Tey SK; Kwong EML; Mao X; Liu BHM; Ma APY; Fung YME; Che CM; Wong DKH; Lai CL; Ng IO; Yam JWP
J Exp Clin Cancer Res; 2019 Oct; 38(1):423. PubMed ID: 31640796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
